OIM
Oracle Investment Management Portfolio holdings
AUM
$116M
This Quarter Return
-0.2%
1 Year Return
+84.31%
3 Year Return
+539.5%
5 Year Return
+791.07%
10 Year Return
+13,222.09%
AUM
$666M
AUM Growth
+$666M
(-16%)
Cap. Flow
-$32M
Cap. Flow
% of AUM
-4.8%
Top 10 Holdings %
Top 10 Hldgs %
88.1%
Holding
25
New
5
Increased
4
Reduced
10
Closed
2
Top Buys
| 1 |
Vir Biotechnology
VIR
|
$23.1M |
| 2 |
DMTK
DermTech, Inc. Common Stock
DMTK
|
$13.4M |
| 3 |
Capricor Therapeutics
CAPR
|
$9.36M |
| 4 |
CDAK
Codiak BioSciences, Inc. Common Stock
CDAK
|
$8.22M |
| 5 |
Y-mAbs Therapeutics
YMAB
|
$7.69M |
Top Sells
| 1 |
QuidelOrtho
QDEL
|
$85.6M |
| 2 |
Pacific Biosciences
PACB
|
$9.16M |
| 3 |
AGEN
Agenus
AGEN
|
$6.74M |
| 4 |
BioCryst Pharmaceuticals
BCRX
|
$6.24M |
| 5 |
Soleno Therapeutics
SLNO
|
$1.94M |
Sector Composition
| 1 | Healthcare | 100% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
BHVN
1
DELISTED
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
| $145M | 21.73% |
2,123,271
-25,000
| -1% | -$1.71M |
|
|
2
QuidelOrtho
QDEL
$1.95B
| $139M | 20.89% |
1,090,309
-669,112
| -38% | -$85.6M |
|
|
AWH
3
DELISTED
Aspira Women's Health Inc. Common Stock
AWH
| $58.4M | 8.74% |
8,647,094
| – | – |
|
4
Opko Health
OPK
$1.1B
| $55M | 8.24% |
12,821,273
-350,000
| -3% | -$1.5M |
|
|
5
Pacific Biosciences
PACB
$393M
| $48.2M | 7.22% |
1,446,459
-275,000
| -16% | -$9.16M |
|
|
DMTK
6
DELISTED
DermTech, Inc. Common Stock
DMTK
| $36.2M | 5.43% |
713,577
+263,577
| +59% | +$13.4M |
|
|
AXDX
7
DELISTED
Accelerate Diagnostics
AXDX
| $31.4M | 4.7% |
3,776,121
-30,018
| -0.8% | -$250K |
|
|
AGEN
8
Agenus
AGEN
$133M
| $25.5M | 3.82% |
9,373,582
-2,478,790
| -21% | -$6.74M |
|
|
9
BioCryst Pharmaceuticals
BCRX
$1.74B
| $24.1M | 3.61% |
2,367,670
-613,200
| -21% | -$6.24M |
|
|
10
Vir Biotechnology
VIR
$686M
| $23.1M | 3.46% |
+450,331
| New | +$23.1M |
|
|
AMRN
11
Amarin Corp
AMRN
$311M
| $12.9M | 1.94% |
2,084,839
+1,052,053
| +102% | +$6.53M |
|
|
12
Y-mAbs Therapeutics
YMAB
$388M
| $11.5M | 1.72% |
380,642
+254,300
| +201% | +$7.69M |
|
|
13
Capricor Therapeutics
CAPR
$287M
| $9.36M | 1.4% |
+1,999,464
| New | +$9.36M |
|
|
CDAK
14
DELISTED
Codiak BioSciences, Inc. Common Stock
CDAK
| $8.22M | 1.23% |
+545,360
| New | +$8.22M |
|
|
ATRS
15
DELISTED
Antares Pharma, Inc.
ATRS
| $7.81M | 1.17% |
1,900,000
| – | – |
|
16
Select Medical
SEM
$1.61B
| $7.67M | 1.15% |
+225,000
| New | +$7.67M |
|
|
CFRX
17
DELISTED
ContraFect Corporation
CFRX
| $7.45M | 1.12% |
1,552,423
+1,384,836
| +826% | +$6.65M |
|
18
Biodesix
BDSX
$62.6M
| $4.78M | 0.72% |
235,511
| – | – |
|
|
MOTS
19
DELISTED
Motus GI Holdings, Inc. Common Stock
MOTS
| $4.54M | 0.68% |
3,747,551
-59,115
| -2% | -$71.5K |
|
|
20
Soleno Therapeutics
SLNO
$3.6B
| $2.69M | 0.4% |
2,132,000
-1,538,384
| -42% | -$1.94M |
|
21
Forian
FORA
$61.3M
| $1.57M | 0.24% |
+155,440
| New | +$1.57M |
|
22
Biogen
BIIB
$19.4B
| $675K | 0.1% |
2,412
-1,276
| -35% | -$357K |
|
|
WBA
23
DELISTED
Walgreens Boots Alliance
WBA
| – | – |
0
| – | – |
|
|
BIOL
24
DELISTED
Biolase, Inc.
BIOL
| – | – |
-1,739,100
| Closed | -$725K |
|
|
TBIO
25
DELISTED
Translate Bio, Inc. Common Stock
TBIO
| – | – |
-100,000
| Closed | -$1.84M |
|